It is organized by the Cancer Therapy and Research Center (CTRC) together with the American Association for Cancer Research (AACR). This year, the fiveday conference will commence on December 9, 2014 and will be held at the Henry B. Gonzalez
Convention Center in San Antonio Texas, USA. The meeting is composed of the following programs:
1. Educational Sessions - these are presentations that will offer updated research findings and background information on areas such as Triple-Negative Breast Cancers, HER2+ Breast Cancer, Molecular Heterogeneity, Neoadjuvant Treatment of ER+ Breast Cancer and Cancer Cell Plasticity,
2. Award Lectures
3. Plenary Lectures
5. Yearly Reviews -invited speakers will be presenting current reviews of their relevant themes under Basic, Translational and Metastatic breast cancer research.
6. Basic Science and Clinical Science Forums - discussion topics includes the new insights into Metastatic Progression, Combination Therapies, and Breast Cancer Mutations.
7. Career Development Forum – a networking session for young investigators including PhDs,
postdocs, and clinical fellows.
Metastasis is a major causative factor of mortality in breast cancer. Increasing evidence, many of which from our laboratory, shows the involvement of the autonomic nervous system in dissemination of breast tumours to distant site. In this conference, my intention is to present my project that addresses the potential role of the nerve growth factor precursor, proNGF, as a therapeutic and diagnostic biomarker in breast cancer metastasis; and its involvement in the dissemination of primary breast tumours through its potential regulation of the autonomic nervous system. This will be an opportunity to showcase my research project on breast cancer fitting within the aims and programs of the symposium. Also, expand the understanding of the disease through knowledge sharing and networking with international researchers in the field of breast cancer research.
Mr Jay Pundavela